Detalhe da pesquisa
1.
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.
Eur J Clin Pharmacol
; 79(4): 503-511, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773042
2.
Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study.
Invest New Drugs
; 40(3): 634-642, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024985
3.
Drug-Induced Kidney Injury Caused by Osimertinib: Report of a Rare Case.
Nephron
; 146(1): 58-63, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34569520
4.
Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study.
J Geriatr Oncol
; 13(2): 207-213, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34602370
5.
Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study.
Transl Lung Cancer Res
; 10(4): 1642-1652, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34012781